Oncology Business Unit

The Oncology Business Unit at Ariel Pharmaceuticals focuses on the development, commercialization, and strategic management of oncology products. This team encompasses various specialized roles, including operations, therapy development, digital and data technology, regulatory affairs, medical affairs, communications, product and pipeline strategy, patient value, policy and access, and regional business operations, ensuring a comprehensive approach to advancing cancer treatments and supporting patients globally.